Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 4 | |
Hold | 8 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for Beam Therapeutics Inc have a median target of 49.00, with a high estimate of 80.00 and a low estimate of 23.00. The median estimate represents a 95.61% increase from the last price of 25.05.
High | 219.4% | 80.00 |
Med | 95.6% | 49.00 |
Low | -8.2% | 23.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +1.43% |
Average growth rate | +29.81% |
More ▼
Revenue history & estimates in USD
Average growth rate | +430.37% |
Average growth rate | +54,121.88% |
More ▼